Who/What: New research on HTS Biosystems' and Applied
Biosystems' proprietary biomolecular kinetic
analysis technology will be presented at IBC Life
Sciences' 13th Annual International Conference on
Antibody Engineering (December 1-4, 2002). This
next-generation microarray-based SPR (surface
plasmon resonsance) system is designed to help
researchers profile and characterize biomolecular
interactions in a parallel format, while
decreasing costs associated with this productive
type of quantitative analysis.
Highlights:
- Early access users of the technology, the
University of Utah and Dyax Corp., will
present their preliminary utility experience
with the system.
- Demonstrations of the technology's user
interface will be offered at the Applied
Biosystems booth at the conference.
Why: - The Antibody Engineering Meeting will
enable HTS Biosystems and Applied Biosystems
to showcase their progress in the
development of advanced, label-free SPR
array technology designed to accelerate drug
discovery R&D with higher throughput,
content-rich biomolecular binding
characterization screening.
Where: Paradise Point Resort
1404 Vacation Road
San Diego, CA 92109
When: The oral research presentations include:
- Sunday, December 1, 1:40 p.m. (PST):
Affinity Biosensing to the nth Degree
(Dr. David Myszka, Center for Biomolecular
Interaction Analysis, University of Utah)
- Monday, December 2, 4:30 p.m. (PST):
A Microarray-Based Surface Plasmon Resonance
Method For the Rapid Determination of Phage
Display Derived Human Antibody Dissociation
Constants
(Dr. Dan Sexton, Investigator, Dyax
Corporation)
Data from the abstracts are embargoed to the
press until after each presentation. For more
information, or to obtain a copy of the abstract,
please visit:
http://www.lifesciencesinfo.com/antibodyeng
About HTS HTS Biosystems, Inc. is a privately held
Biosystems: biotechnology company specializing in
high-throughput bioanalytical systems for the
rapidly growing field of proteomics. HTS
Biosystems offers a unique portfolio of
innovative technologies that support all phases
of proteomics, from discovery to development of
therapeutic and diagnostic products. The
company's technology platform - the
Proteomatrix(TM) Solution - streamlines the
discovery process and captures fixed costs for
more effective use of protein data in target
screening, validation, and discovery efforts.
Collaborations with key industry partners, such
as Applied Biosystems, Dyax Corporation,
Mitsubishi Chemical Corporation, and Molsoft LLC
have driven the development of the company's
technologies and related systems, including the
joint HTS Biosystems-Applied Biosystems
next-generation SPR array technology platform,
the CHEMI FLEX(TM) System, and the PHASE FLEX(TM)
System for target discovery, screening and
validation. HTS Biosystems' operations are
located in Hopkinton, MA. For more information,
visit www.htsbiosystems.com
About Applied Applied Biosystems, a business unit of Applera
Biosystems: Corporation, develops and markets
instrument-based systems, reagents, software, and
contract related services to the life science
industry and research community. These
technologies enable biological discoveries in
life science research, pharmaceutical research
and development, diagnostics, and agriculture.
Its broad portfolio of technologies, which
includes DNA sequencing, PCR, organic synthesis,
chemiluminescence, mass spectrometry, and
information management systems, enable genomics,
proteomics, high throughput screening, and other
molecular analyses. For more information, visit:
http://www.appliedbiosystems.com
Comments
Post a Comment